These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 20487047)

  • 1. Enhancing transparency and efficiency in reporting industry-sponsored clinical research: report from the Medical Publishing Insights and Practices initiative.
    Clark J; Gonzalez J; Mansi B; Miller C; Mooney LA; Mosdell K; Richards D; Schreiweis M; Weigel A; Wager E
    Int J Clin Pract; 2010 Jul; 64(8):1028-33. PubMed ID: 20487047
    [No Abstract]   [Full Text] [Related]  

  • 2. Authors' Submission Toolkit: a practical guide to getting your research published.
    Chipperfield L; Citrome L; Clark J; David FS; Enck R; Evangelista M; Gonzalez J; Groves T; Magrann J; Mansi B; Miller C; Mooney LA; Murphy A; Shelton J; Walson PD; Weigel A
    Curr Med Res Opin; 2010 Aug; 26(8):1967-82. PubMed ID: 20569069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sponsorship, authorship and accountability.
    Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke AJ; Sox HC; Van Der Weyden MB; Wilkes MS;
    CMAJ; 2001 Sep; 165(6):786-8. PubMed ID: 11584570
    [No Abstract]   [Full Text] [Related]  

  • 4. Industry sponsorship in research and publishing: who is really to blame for perceived bias?
    Amsden GW
    Ann Pharmacother; 2004 Apr; 38(4):714-6. PubMed ID: 14982974
    [No Abstract]   [Full Text] [Related]  

  • 5. [Good initiative].
    Engel T
    Ugeskr Laeger; 2001 Nov; 163(46):6451. PubMed ID: 11816929
    [No Abstract]   [Full Text] [Related]  

  • 6. [More stringent requirements concerning manuscripts. Declarations of potential connections and conflicts of interest published in the Lakartidningen].
    Milerad J; Ahlberg J; Eliasson M; Fridén B; Håkansson A; Sundberg CJ; Agren H; Ostergren J
    Lakartidningen; 2002 Apr; 99(15):1662-3. PubMed ID: 12025190
    [No Abstract]   [Full Text] [Related]  

  • 7. Between the lines: navigating the uncharted territory of industry-sponsored research.
    Davidoff F
    Health Aff (Millwood); 2002; 21(2):235-42. PubMed ID: 11900164
    [No Abstract]   [Full Text] [Related]  

  • 8. Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry-sponsored clinical trials.
    Matcham J; Julious S; Pyke S; O'Kelly M; Todd S; Seldrup J; Day S
    Pharm Stat; 2011; 10(1):70-3. PubMed ID: 20187020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Data availability for industry sponsored trials: what should medical journals require?
    Steinbrook R; Kassirer JP
    BMJ; 2010 Oct; 341():c5391. PubMed ID: 20940213
    [No Abstract]   [Full Text] [Related]  

  • 10. Industry sponsorship and authorship of clinical trials over 20 years.
    Buchkowsky SS; Jewesson PJ
    Ann Pharmacother; 2004 Apr; 38(4):579-85. PubMed ID: 14982982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ethics and industry-sponsored research.
    Kuebler C; Nimmo WS; von R; Gillings D; Morgan AT; Kendle C; Covington PS
    CMAJ; 2002 Mar; 166(5):579-80; author reply 582. PubMed ID: 11898930
    [No Abstract]   [Full Text] [Related]  

  • 12. Sponsorship, authorship, and accountability.
    Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke AJ; Sox HC; Van Der Weyden MB; Wilkes MS
    N Engl J Med; 2001 Sep; 345(11):825-6; discussion 826-7. PubMed ID: 11556304
    [No Abstract]   [Full Text] [Related]  

  • 13. Sponsorship, authorship and accountability.
    Loder E
    N Z Med J; 2001 Dec; 114(1145):559. PubMed ID: 11833961
    [No Abstract]   [Full Text] [Related]  

  • 14. [Researchers' free right of publishing].
    Andersen D
    Ugeskr Laeger; 2001 Oct; 163(44):6154. PubMed ID: 11715166
    [No Abstract]   [Full Text] [Related]  

  • 15. Research accountability and financial conflicts of interest in industry-sponsored clinical research: a review.
    Tereskerz PM
    Account Res; 2003; 10(3):137-58. PubMed ID: 14979317
    [No Abstract]   [Full Text] [Related]  

  • 16. [Knowledge on feet of clay].
    Dahlqvist R
    Lakartidningen; 2008 May 7-13; 105(19):1405-6. PubMed ID: 18574980
    [No Abstract]   [Full Text] [Related]  

  • 17. Sponsorship, authorship, and accountability.
    Davidoff F; Deangelis CD; Drazen JM; Nicholls MG; Hoey J; Hojgaard L; Horton R; Kotzin S; Nylenna M; Overbeke JP; Sox HC; Van der Weyden MB; Wilkes MS;
    Ugeskr Laeger; 2001 Sep; 163(37):4983-5. PubMed ID: 11573367
    [No Abstract]   [Full Text] [Related]  

  • 18. Sponsorship, authorship and accountability.
    Davidoff F; DeAngelis CD; Drazen JM; Nicholls MG; Hoey J; Højgaard L; Horton R; Kotzin S; Nylenna M; Overbeke JP; Sox HC; Van der Weyden MB; Wilkes MS
    Lakartidningen; 2001 Oct; 98(43):4694-6. PubMed ID: 11715244
    [No Abstract]   [Full Text] [Related]  

  • 19. Comments on 'The potential for bias in the reporting of industry sponsored clinical trials' by Stephen Pyke et al. and 'Proposed best practice for statisticians in the reporting and publication of pharmaceutical industry sponsored clinical trials' by James Matcham et al. Pharmaceutical Statistics.
    Campbell MJ
    Pharm Stat; 2011; 10(1):80-1. PubMed ID: 21275038
    [No Abstract]   [Full Text] [Related]  

  • 20. Medicine in the Noise Age: what can we believe?
    Angell M
    Account Res; 2001; 8(3):189-95. PubMed ID: 12481786
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.